Orgenesis INC. (ORGS) — 10-K Filings
All 10-K filings from Orgenesis INC.. Browse 2 Annual Report reports with AI-powered summaries and risk analysis.
10-K Filings (2)
-
Orgenesis Shifts to OTC, Eyes Decentralized Cell Therapy Growth
— Mar 26, 2026 Risk: high
Orgenesis Inc. (ORGS) is a global biotech company focused on making cell and gene therapies (CGTs) affordable and accessible through its decentralized cell proc -
Orgenesis Inc. Files 2023 Annual Report on Form 10-K
— Apr 15, 2024 Risk:
Orgenesis Inc. (ORGS) filed a Annual Report (10-K) with the SEC on April 15, 2024. Orgenesis Inc. filed its 10-K report for the fiscal year ending December 31,
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX